Life Sciences Transformational R&D Investment Fund (TRIF) Pilot
Department for Science, Innovation and Technology (DSIT) · United Kingdom
The TRIF Pilot provides capital grants to support large-scale R&D investments in the UK life sciences sector, focusing on innovation, health resilience, and economic growth.
Summary
Deadline
30 Mar 2028
Complexity
Medium
Time to apply
20-60 hours
Updated
9 Jun 2026
The TRIF Pilot provides capital grants to support large-scale R&D investments in the UK life sciences sector, focusing on innovation, health resilience, and economic growth.
Eligibility
Applicant types
Business
Business size
SME, Large
Industries
Life sciences, pharmaceuticals, medical diagnostics, MedTech
Match funding
Needs verification
Requirements
UK-registered private sector businesses operating as product developers, CDMOs, or generics manufacturers Verification Required — TRIF pilot for life sciences transformational R&D. Human medicines; medical diagnostics; medical devices
Eligible applicants
UK-registered private sector businesses operating as product developers, CDMOs, or generics manufacturers
Funding and scope
Benefit amount
£50,000,000
Total fund available
£50,000,000
Funding intensity
Verification Required
Payment type
Reimbursement
Eligible scope
Human medicines; medical diagnostics; medical devices
Eligible expenses
Not specified
Ineligible costs
- Verification Required
Application and risks
Application platform
Online portal via Expression of Interest (EOI) process
Competitiveness
Competitive Selection
Decision timeline
Not specified
Assessment process
Multi-stage process including EOI screening, panel interview, and due diligence assessment
Application sections
Not specified
Application components
- Expression of Interest
- Application Form 1 (EOI)
- Application Form 2
- supporting financial and project documentation
Required documents
Not specified
Appendices
Not specified
Assessment criteria
- Health resilience and innovation impact
- economic impact
- financial viability
- project deliverability
Timeline and partners
Opening date
25 Sept 2025
Project duration
Verification Required
Project start
Not specified
Project end
Not specified
Co-funders
Not specified
Collaboration rules
- Verification Required
Consortium requirements
- Verification Required
Additional guidance
[{"label":"Key Organisational Requirements","value":"Must be a UK-registered private company; provide audited accounts or proof of secured funding; demonstrate track record in life sciences development or manufacturing"},{"label":"Funding Structure","value":"Typically 10% to 20% of total project costs; projects must exceed £100 million in total value"},{"label":"important notes","value":"Rolling application process; grant awards capped at £25 million; projects must be dependent on funding to proceed; compliance with UK subsidy control regulations required"}]
Quick facts
- Status
- Open
- Deadline
- 30 Mar 2028
- Funding amount
- £50,000,000
- Funding band
- Large (£5M+)
- Funding type
- Capital grant
- Payment type
- Reimbursement
- Audience
- Business
- Industry
- Life sciences, pharmaceuticals, medical diagnostics, MedTech
- Last updated
- 9 Jun 2026
- Published
- 25 Sept 2025